Comparative study of tacrolimus and bevacizumab on corneal neovascularization in rabbits. [electronic resource]
Producer: 20150924Description: 449-55 p. digitalISSN:- 1536-4798
- Administration, Topical
- Angiogenesis Inhibitors -- therapeutic use
- Animals
- Antibodies, Monoclonal, Humanized -- therapeutic use
- Bevacizumab
- Chemokine CCL2 -- genetics
- Conjunctiva -- drug effects
- Corneal Neovascularization -- drug therapy
- Disease Models, Animal
- Immunosuppressive Agents -- therapeutic use
- Injections, Intraocular
- Interferon-gamma -- genetics
- Interleukin-1beta -- genetics
- Ophthalmic Solutions
- RNA, Messenger -- genetics
- Rabbits
- Real-Time Polymerase Chain Reaction
- Tacrolimus -- therapeutic use
- Tumor Necrosis Factor-alpha -- genetics
- Vascular Endothelial Growth Factor A -- antagonists & inhibitors
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.